ABL Bio Inc. (KOSDAQ:298380)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Biotechnology (Startups)	79.35B	33.40B	65.55B	67.30B	5.33B
Total	79.35B	33.40B	65.55B	67.30B	5.33B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
South Korea	400.00M	300.00M	2.00B	2.38B	483.55M
United States	5.77B	33.10B	63.55B	62.32B	4.85B
UK	73.18B	-	-	-	-
China	-	-	-	2.60B	-
Total	79.35B	33.40B	65.55B	67.30B	5.33B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error